GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Eyebright Medical Technology (Beijing) Co Ltd (SHSE:688050) » Definitions » PS Ratio

Eyebright Medical Technology (Beijing) Co (SHSE:688050) PS Ratio : 14.59 (As of Apr. 13, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Eyebright Medical Technology (Beijing) Co PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Eyebright Medical Technology (Beijing) Co's share price is ¥104.56. Eyebright Medical Technology (Beijing) Co's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was ¥7.17. Hence, Eyebright Medical Technology (Beijing) Co's PS Ratio for today is 14.59.

Warning Sign:

Eyebright Medical Technology (Beijing) Co Ltd stock PS Ratio (=14.55) is close to 1-year high of 15.57.

The historical rank and industry rank for Eyebright Medical Technology (Beijing) Co's PS Ratio or its related term are showing as below:

SHSE:688050' s PS Ratio Range Over the Past 10 Years
Min: 10.69   Med: 38.56   Max: 98.02
Current: 14.6

During the past 8 years, Eyebright Medical Technology (Beijing) Co's highest PS Ratio was 98.02. The lowest was 10.69. And the median was 38.56.

SHSE:688050's PS Ratio is ranked worse than
89.95% of 806 companies
in the Medical Devices & Instruments industry
Industry Median: 2.86 vs SHSE:688050: 14.60

Eyebright Medical Technology (Beijing) Co's Revenue per Sharefor the three months ended in Sep. 2024 was ¥2.06. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was ¥7.17.

During the past 12 months, the average Revenue per Share Growth Rate of Eyebright Medical Technology (Beijing) Co was 69.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was 43.40% per year. During the past 5 years, the average Revenue per Share Growth Rate was 36.50% per year.

During the past 8 years, Eyebright Medical Technology (Beijing) Co's highest 3-Year average Revenue per Share Growth Rate was 58.70% per year. The lowest was 30.30% per year. And the median was 39.20% per year.

Back to Basics: PS Ratio


Eyebright Medical Technology (Beijing) Co PS Ratio Historical Data

The historical data trend for Eyebright Medical Technology (Beijing) Co's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eyebright Medical Technology (Beijing) Co PS Ratio Chart

Eyebright Medical Technology (Beijing) Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PS Ratio
Get a 7-Day Free Trial - 56.63 51.02 41.91 19.09

Eyebright Medical Technology (Beijing) Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.58 19.09 12.69 11.30 13.87

Competitive Comparison of Eyebright Medical Technology (Beijing) Co's PS Ratio

For the Medical Instruments & Supplies subindustry, Eyebright Medical Technology (Beijing) Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eyebright Medical Technology (Beijing) Co's PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Eyebright Medical Technology (Beijing) Co's PS Ratio distribution charts can be found below:

* The bar in red indicates where Eyebright Medical Technology (Beijing) Co's PS Ratio falls into.


;
;

Eyebright Medical Technology (Beijing) Co PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Eyebright Medical Technology (Beijing) Co's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=104.56/7.165
=14.59

Eyebright Medical Technology (Beijing) Co's Share Price of today is ¥104.56.
Eyebright Medical Technology (Beijing) Co's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥7.17.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Eyebright Medical Technology (Beijing) Co  (SHSE:688050) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Eyebright Medical Technology (Beijing) Co PS Ratio Related Terms

Thank you for viewing the detailed overview of Eyebright Medical Technology (Beijing) Co's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Eyebright Medical Technology (Beijing) Co Business Description

Traded in Other Exchanges
N/A
Address
No. 9, Xingchang Road, Science and Technology Park, Changping District, Beijing, CHN, 102200
Eyebright Medical Technology (Beijing) Co Ltd is engaged in research and development, production, sales and related services of ophthalmic medical devices. The company's product range includes Intraocular Lens; IOL Delivery System; Ophthalmic Instruments; Other Products; Literature; and Expert Interview.
Executives
Jia Bao Shan senior management
Wang Zhao Directors, senior managers, core technical personnel
Jie Jiang Bing Directors, senior managers, core technical personnel

Eyebright Medical Technology (Beijing) Co Headlines

No Headlines